Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 27;13(7):292.
doi: 10.3390/dj13070292.

Effects of Oral Appliance Therapy with a Mouth Shield in Periodontitis Patients Who Snore: A Split-Mouth Randomized Controlled Trial

Affiliations

Effects of Oral Appliance Therapy with a Mouth Shield in Periodontitis Patients Who Snore: A Split-Mouth Randomized Controlled Trial

Ju-Ying Lin et al. Dent J (Basel). .

Abstract

Background: Periodontitis is linked to sleep-disordered breathing (SDB), including snoring, with 50-75% of cases involving mouth breathing (MB). Standard treatment includes scaling and root planing (SRP). Oral appliance therapy (OAT) is used to treat snoring and SDB. OAT plus a mouth shield (OAT+) worn during sleep may reduce MB to enhance periodontal health. This study evaluated whether OAT+, as an adjunct to SRP, improves periodontal health by reducing periodontal pathogens and facilitating upper airway patency. Methods: Fourteen participants with mild-moderate periodontitis were randomized to receive SRP on one side of the mouth at baseline (T0). Pocket depth (PD), bleeding on probing (BOP), and plaque index (PI) were recorded, and bacterial DNA from periodontal pockets were analyzed via PCR at baseline (T0) and 12 weeks (T3). At 4 weeks (T1), all participants received a self-titrated myTAP® OA, followed by a mouth shield at 8 weeks (T2). Sleep metrics, including respiratory disturbance index (RDI), were recorded using the NOX T3 at T0-T3. Results: BOP and deep PD levels exhibited slight improvements from the baseline for both SRP and non-SRP (OAT+ only) treated sites but did not achieve significance. BOP decreased significantly more from the baseline in the SRP than in the non-SRP group at T3 (p = 0.028); P. gingivalis' presence declined on both sides (p = 0.0135). Other periodontal and bacterial parameters showed no significant differences between or within groups. Snoring (p = 0.011), MB (p = 0.025), and RDI (p = 0.019) significantly decreased with OAT+ at T3. Conclusions: In mild-moderate periodontitis patients who snore, OAT+ reduces snoring, MB, and obstructive events, serving as an adjunct to SRP with no negative clinical effects over the short term. The combined therapy yielded similar results to OAT+ alone, likely due to minimization of MB. Its capacity to improve the oral environment is worthy of further investigation.

Keywords: microbiology; mouth breathing; oral appliance; periodontitis; sleep apnea.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
myTAP oral appliance with the mouth shield in place. (sourced from Airway Management, Inc., Farmers Branch, TX, USA).
Figure 2
Figure 2
A patient wearing a myTAP oral appliance. (sourced from Airway Management, Inc.).
Figure 3
Figure 3
CONSORT flow diagram with attrition; OA, oral appliance.

References

    1. Trindade D., Carvalho R., Machado V., Chambrone L., Mendes J.J., Botelho J. Prevalence of periodontitis in dentate people between 2011 and 2020: A systematic review and meta-analysis of epidemiological studies. J. Clin. Periodontol. 2023;50:604–626. doi: 10.1111/jcpe.13769. - DOI - PubMed
    1. Marsh P.D., Zaura E. Dental biofilm: Ecological interactions in health and disease. J. Clin. Periodontol. 2017;44((Suppl. S18)):S12–S22. doi: 10.1111/jcpe.12679. - DOI - PubMed
    1. Cobb C.M. Clinical significance of non-surgical periodontal therapy: An evidence-based perspective of scaling and root planing. J. Clin. Periodontol. 2002;29((Suppl. S2)):6–16. doi: 10.1034/j.1600-051X.29.s2.4.x. - DOI - PubMed
    1. Pihlstrom B.L., Ortiz-Campos C., McHugh R.B. A randomized four-years study of periodontal therapy. J. Periodontol. 1981;52:227–242. doi: 10.1902/jop.1981.52.5.227. - DOI - PubMed
    1. Sanz M., Herrera D., Kebschull M., Chapple I., Jepsen S., Beglundh T., Sculean A., Tonetti M.S., Participants E.F.P.W., Methodological C. Treatment of stage I–III periodontitis-The EFP S3 level clinical practice guideline. J. Clin. Periodontol. 2020;47((Suppl. S22)):4–60. doi: 10.1111/jcpe.13290. - DOI - PMC - PubMed

LinkOut - more resources